20/06/2017

ESTEVE RECEIVES THE AVENZOAR AWARD FOR BEST COLLABORATION WITH PHARMACY

With this award, the Avenzoar Pharmaceutical Foundation acknowledges ESTEVE's commitment to the daily tasks of pharmaceutical professionals in their role as health agents.

The Pharmaceutical Foundation Avenzoar, which depends on the Royal Association of Pharmacists of Seville, decided to grant ESTEVE the Award to the Laboratory that has best distinguished itself as a collaborator with Pharmacy.

The award ceremony was held at the Auditorium of the University of Seville, and ESTEVE Regional Director Pepe García accepted the award on behalf of the company from Mr. Manuel Pérez, president of the Royal Association of Pharmacists of Seville and patron of the Avenzoar Foundation.

The Avenzoar Pharmaceutical Foundation is an entity devoted to scientific and technical research in the field of pharmaceutical sciences. On a yearly basis, it grants these awards to initiatives launched by institutions and personalities related to science, pharmacy, health care, and culture.

You can follow ESTEVE on Twitter: twitter.com/esteve_news.

Last news

  • THE PROGRAM ’PLAN PROFARMA’ HAS ONCE AGAIN QUALIFIED ESTEVE’S R&D&I AS ’’EXCELLENT’’

    Once again, ESTEVE's research activity has received the qualification ''Excellent'' in the Program 'Plan Profarma' (Program for Fostering Scientific Research, Technological Development and Innovation ...

    read more
  • PENSA PHARMA HAS BEEN AWARDED A PRIZE FOR ITS BEST DEVELOPMENT AND COMMERCIALIZATION OF GENERIC MEDICINES

    Pensa Pharma (PENSA), a company of the ESTEVE Group specialized in generic medicines, has been awarded a prize at the II edition of La Razón Comunidad Valenciana Awards. Specifically, PENSA has receiv...

    read more
  • ESTEVE APPOINTS THOMAS B. RIISAGER AS CHIEF CORPORATE STRATEGY & BUSINESS DEVELOPMENT OFFICER

    ESTEVE has announced today the appointment of Thomas B Riisager as Chief Corporate Strategy & Business Development Officer, to be heading Corporate Strategy & Business Development for the pharmaceutic...

    read more

Follow us at

This Website uses its own and third-party cookies to improve our services and analyse the user's browsing habits. If you continue browsing, we will consider you to have accepted their use. You can find more information by visiting our Cookies policy.